Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

COVID-19 has claimed millions of lives during the last 3 years since initial cases were
reported in Wuhan, China, in 2019. Patients with COVID-19 suffer from severe pneumonia …

Macrophages play diverse roles in development, homeostasis, and immunity. Accordingly,
the dysfunction of macrophages is involved in the occurrence and progression of various …

Acute respiratory distress syndrome (ARDS) is a heterogeneous cause of respiratory failure
that has a rapid onset, a high mortality rate, and for which there is no effective …

Drug repurposing, also known as drug repositioning, entails the application of pre-approved
or formerly assessed drugs having potentially functional therapeutic amalgams for curing …

COVID-19 is a severe respiratory illness that has emerged as a devasting health problem
worldwide. The disease outcome is heterogeneous, which is most likely dependent on the …

Objectives To investigate the efficacy and safety of otilimab, an anti-granulocyte-
macrophage colony-stimulating factor antibody, in patients with active rheumatoid arthritis …

Objectives To investigate the efficacy and safety of otilimab, an antigranulocyte-macrophage
colony-stimulating factor antibody, in patients with active rheumatoid arthritis. Methods Two …

ABSTRACT Introduction Acute Respiratory Distress Syndrome (ARDS) is a heterogeneous
form of lung injury with severe hypoxemia and bilateral infiltrates after an inciting event that …

Introduction The emergence of new SARS-CoV-2 variants, capable of escaping the humoral
immunity acquired by the available vaccines, together with waning immunity and vaccine …